--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--------
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 22.840
- +0.450+2.01%
Close Nov 29 13:00 ET
- 22.840
- 0.0000.00%
Post 13:01 ET
835.41MMarket Cap-11629P/E (TTM)
23.200High21.900Low30.11KVolume22.700Open22.390Pre Close677.85KTurnover0.33%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.59P/B210.13MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM5.81%Amplitude16.550Historical Low22.512Avg Price1Lot Size
Rapport Therapeutics Key Stats
Rapport Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Rapport Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data